3 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Knoa Pharma LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic (PK) Evaluation of Nalmefene Formulations Nalmefene + 0.94% MgCl2, Nalmefene Hydrochloride Injection - Opioid Overdose | Phase 1 | Completed | Knoa Pharma LLC | 13 | 2026-02-06 | 2026-06-05 |
| Study of Sunobinop on Craving in Alcohol Use Disorder Sunobinop, Placebo to match sunobinop - Alcohol Use Disorder | Phase 2 | Completed | Knoa Pharma LLC | 40 | 2025-01-28 | 2026-07-07 |
| Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder Sunobinop, Placebo to match sunobinop - Alcohol Use Disorder | Phase 2 | Completed | Knoa Pharma LLC | 209 | 2024-10-14 | 2026-06-05 |
Alcoholism (2) · Alcohol Drinking (1) · Opiate Overdose (1)
Magnesium Chloride (1) · nalmefene (1)
United States (3) · Romania (1)